Those patients taking the blood thinner, Xarelto, still don’t know
that they are at an increased risk for bleeding to death. That’s
because Xarelto manufacturers have kept that secret pretty well hidden.
Now, lawsuits across the country are cropping up, after patients taking
Xarelto have bled to death or experienced serious injury.
Unlike traditional blood thinners, Coumadin or Heparin, there is no known
antidote to stop uncontrolled bleeding. Xarelto was marketed and released
to the public without one. While Xarelto manufacturers are working on
the antidote, none presently exists - and many people have been injured
or killed as a result. To date, there have been at least 65 deaths attributed
to Xarelto bleeding complications - with that number expected to climb
quickly into the thousands.
Those taking Xarelto who have any of the following issues may be at a much
higher risk of developing paralysis or uncontrolled bleeding:
- Patients who have previously had spinal surgery
- Patients with current spinal problems
- Patients currently taking other blood thinners
- Patients currently taking NSAIDS
- Patients with an epidural catheter
If you were harmed by the drug Xarelto, you could be entitled to collect
compensation from the manufacturer for current and future medical expenses
as well as damages for pain and suffering. Every lawsuit filed also holds
the manufacturers of Xarelto accountable for releasing a potentially dangerous
drug to consumers.
How Dangerous is Xarelto?
A report from the Institute for Safe Medication Practices identified 356
reports of serious, disabling, or fatal injury in which Xarelto was the
primary suspect drug. In March 2014, the FDA required a black box warning
be added to Xarelto, which warns of the risks of using Xarelto when the
patient will have an epidural or spinal anesthesia or spinal puncture.
Physicians are asked to monitor patients taking Xarelto and undergoing
one of these procedures in order to detect signs of neurological impairment,
sensory and motor deficits, and bowel or bladder dysfunction.
In some cases, paralysis can result in patients taking Xarelto and undergoing
spinal/epidural anesthesia or puncture. Although the FDA has not placed
uncontrollable bleeding in a black box warning, it did require the manufacturer
to warn of the potential for uncontrollable bleeding under "adverse
reactions." In 2013, the FDA issued a warning letter to Janssen stating
the print advertisement for Xarelto minimized the risks associated with
the drug and made misleading claims. The FDA stated that including risk
information without the same emphasis included in the benefit section
made it appear as though the risks were unimportant.
Need more information about Xarelto? Call us at Golomb & Honik, P.C.
at (215) 278-4449.